|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07K 14/605 | |
| A61K 47/48 |
| (11) | Patento numeris | 2513140 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 10788095.7 |
| Europos patento paraiškos padavimo data | 2010-12-16 | |
| (97) | Europos patento paraiškos paskelbimo data | 2012-10-24 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2015-11-04 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/EP2010/069932 |
| Data | 2010-12-16 |
| (87) | Numeris | WO 2011/080103 |
| Data | 2011-07-07 |
| (30) | Numeris | Data | Šalis |
| 288601 P | 2009-12-21 | US | |
| 09179390 | 2009-12-16 | EP |
| (72) |
GARIBAY, Patrick, William, DK
SPETZLER, Jane, DK
KODRA, Jįnos, Tibor, DK
LINDEROTH, Lars, DK
LAU, Jesper, DK
SAUERBERG, Per, DK
|
| (73) |
Novo Nordisk A/S,
Novo Allé, 2880 Bagsvęrd,
DK
|
| (54) | DOUBLE-ACYLATED GLP-1 DERIVATIVES |
| DOUBLE-ACYLATED GLP-1 DERIVATIVES |